José D. Luna

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.

Hiroaki Ozaki, Aimee Y. Yu, Neil G. Della et al. · PubMed · 1999 · 328 citations

Targeted Disruption of the FGF2 Gene Does Not Prevent Choroidal Neovascularization in a Murine Model

Takao Tobe, Sagrario Ortega, José D. Luna et al. · American Journal Of Pathology · 1998 · 327 citations · Full text

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.

Stanley A. Vinores, Ayman Youssri, José D. Luna et al. · PubMed · 1997 · 237 citations

Retinal Neurons, Ocular Disease, Immunology +21